Dr. Peter GK Mathen, M.D.
Claim this profileStudies Brain Astrocytoma
Studies Glioblastoma
1 reported clinical trial
1 drug studied
Clinical Trials Peter GK Mathen, M.D. is currently running
More about Peter GK Mathen, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Peter GK Mathen, M.D. has experience with
- Hypofractionation Trial Of Re-irradiation
Breakdown of trials Peter GK Mathen, M.D. has run
Brain Astrocytoma
Glioblastoma
Astrocytoma
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter GK Mathen, M.D. specialize in?
Peter GK Mathen, M.D. focuses on Brain Astrocytoma and Glioblastoma. In particular, much of their work with Brain Astrocytoma has involved treating patients, or patients who are undergoing treatment.
Is Peter GK Mathen, M.D. currently recruiting for clinical trials?
Yes, Peter GK Mathen, M.D. is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Peter GK Mathen, M.D. has studied deeply?
Yes, Peter GK Mathen, M.D. has studied treatments such as Hypofractionation Trial of Re-irradiation.
What is the best way to schedule an appointment with Peter GK Mathen, M.D.?
Apply for one of the trials that Peter GK Mathen, M.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.